Leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, to develop new medicines to treat cancer patients.

Leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, to develop new medicines to treat cancer patients.

LEARN MORE

Leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, to develop new medicines to treat cancer patients.

LATEST NEWS

Tasca Therapeutics Doses First Patient in Phase 1/2 Dose Escalation and Expansion Trial Evaluating CP-383 in Advanced Solid Tumors

Tasca Therapeutics Launches with $52 Million Series A Financing to Develop Small Molecule Inhibitors for Multiple Oncology Indications